Drug Search Results

Tolperisone

Alternative Names: tolperisone, tolperison
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ADR Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Neurana Pharmaceuticals, Inc.
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Acute Pain|Low Back Pain

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
2021-006042-13	P3	Completed	Acute Pain\|Low Back Pain	2023-02-03

Recent News Events

Date	Type	Title
05/01/2024	PubMed	Tolperisone hydrochloride improves motor functions in Parkinson's disease via MMP-9 inhibition and by downregulating p38 MAPK and ERK1/2 signaling cascade.
04/09/2024	PubMed	Symptomatic Cavum Vergae Cyst in a Geriatric Patient: A Report of a Rare Case and Conservative Management Approach.
08/01/2023	PubMed	Effects of CYP2D6 and CYP2C19 genetic polymorphisms and cigarette smoking on the pharmacokinetics of tolperisone.
03/22/2022	News Article	Neurana Pharmaceuticals Seeks Strategic Alternatives Following Phase 3 Study
11/29/2021	News Article	Neurana Pharmaceuticals Completes Patient Enrollment in Phase 3 RESUME-1 Study
11/24/2021	News Article	Neurana Pharmaceuticals to Present at Piper Sandler Healthcare Conference
09/02/2021	News Article	Neurana Pharmaceuticals to Present at Wells Fargo Virtual Healthcare Conference

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions